Nomura Asset Management International’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Nomura Asset Management International's REGN Position: Q2 2026 in Review
Nomura Asset Management International reduced its Regeneron Pharmaceuticals (REGN) stake by 14% in Q2 2026, selling an estimated $5.08M and leaving 47,005 shares worth $29.3M. The position accounts for 0.04% of the portfolio, ranked #495.
Nomura Asset Management International first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $42.9M in Q4 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Nomura Asset Management International held 47,005 shares of Regeneron Pharmaceuticals worth $29.3M as of Q2 2026.
- Nomura Asset Management International sold 7,470 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $5.08M.
- Regeneron Pharmaceuticals made up 0.04% of Nomura Asset Management International's portfolio in Q2 2026, its #495 holding.
- Nomura Asset Management International first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Nomura Asset Management International's Regeneron Pharmaceuticals position peaked at $42.9M in Q4 2025.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.